Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record history now includes a new revision v3.4.3 and removes revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T10:15:33.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history. The government funding notice banner previously shown on the page was removed.
    Difference
    0.8%
    Check dated 2026-02-11T02:13:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new government funding notice was added and the recruitment status was updated to Active, not recruiting (revision v3.4.1, 2026-01-29). Earlier statuses such as insufficient accrual and Terminated were removed (revision v3.4.0, 2025-08-06).
    Difference
    2%
    Check dated 2026-02-04T00:23:21.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary option added and color-coded change legends introduced with explanatory text; revision notes moved to v3.4.0 (removing v3.3.4) and the No FEAR Act label capitalization updated.
    Difference
    1%
    Check dated 2026-01-27T23:52:55.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-01-13T19:22:04.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new site revision entry Revision: v3.3.3 was added. The items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:29:05.000Z thumbnail image

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.